We found that patients with severe COVID-19 and diabetes had greater frequencies of CD62L+ CD4+ T cells compared to diabetics with non-severe COVID-19 (p<0.01) and non-diabetics with non-severe (p=0.02) or severe disease (p=0.04) (Figure 5A). The gene discussed is SELL; the disease is COVID-19.